(Bloomberg) -- Global coronavirus cases topped 5 million, doubling in the past month, and infections rose at a record pace in Brazil and Indonesia. AstraZeneca received $1.2 billion in U.S. funding to develop a vaccine, while CanSino Biologics signed a deal to test and sell a Canadian vaccine candidate.The U.K. agreed a deal to acquire antibody tests, a boost to Prime Minister Boris Johnson as he tries to ease the country back to normality. U.S. President Donald Trump suggested Chinese leader Xi Jinping was behind a “disinformation and propaganda attack,” and is set to tour Ford’s ventilator facility.More than 2 million Americans applied for unemployment benefits last week, indicating major job losses are continuing. The U.S. Transportation Security Administration has started making changes to airport screening, and EasyJet plans to resume flights from some European airports in June.Key Developments:Virus Tracker: Cases reached 5 million; deaths exceed 328,000Why a new cluster in...
(Bloomberg) -- Bond investors are skeptical that inflation will rebound as the U.S. economy eventually starts to recover.While some lawmakers fretted this week that a combination of central bank and government rescue packages could inflame long-dormant price pressures, the market’s outlook for inflation has languished. Investors aren’t betting on outright deflation over the longer term, but the 10-year breakeven rate -- a gauge of traders’ expectations for the consumer price index over the next decade based on Treasury prices -- is hovering around 1.15%. The 30-year is less than half a percentage point higher.That means investors don’t see the Federal Reserve getting close to its 2% inflation target before 2050. That outlook isn’t a great set up for the Treasury’s $12 billion sale of 10-year inflation-linked bonds Thursday. The historic slump in West Texas crude oil prices, which have clawed back from below zero to trade above $34 a barrel, and...
Is it May 2020 or March 2009? As Wall Street observers traverse the confused economic environment, flashbacks of the Great Recession are coming to mind. Those looking at the glass half empty will point out the bear market that emerged took 18 months to reach the lowest point. However, the optimists are singing a different tune.Among the bulls is Morgan Stanley’s head of U.S. equity strategy, Michael Wilson. In a recent note to clients, he argues that the current state of the market bears a striking resemblance to March 2009, the period in which the U.S. economy began to recover, with the S&P 500 embarking on what would become the longest bull-market run on record.“Markets are tracking the Great Financial Crisis period very closely in many ways,” Wilson wrote. To support this claim, the strategist highlights the fact that stocks are bouncing back in a “similar pattern," at the same time...
Chinese tech stock Baidu (BIDU) may delist from Nasdaq and transfer to an exchange closer to China, such as Hong Kong, Reuters reports. According to three Reuters sources, Baidu would use the move to boost its valuation as tension continues to escalate between the US and China over investments.“For a good company, there are many choices of destinations for listing, not limited to the U.S.,” CEO Robin Li recently told the China Daily newspaper.On May 20, the Senate passed legislation forcing US-listed companies to confirm that “they are not owned or controlled by a foreign government.”Shares in Baidu are currently trading down 14% on a year-to-date basis, and 43% on a three-year basis.“We believe the shares are undervalued, as we estimate core EBITDA growing 23% in FY21. Target assumes 7x ’21E core EBITDA vs. our 10x target multiple for Google core search” pointed out Oppenheimer analyst Jason Helfstein, as he reiterated his...